Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $19.17.
A number of equities analysts have weighed in on the stock. Mizuho reiterated a "neutral" rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Citizens Jmp upgraded Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a report on Tuesday, January 7th. JMP Securities upgraded Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price target for the company in a research note on Tuesday, January 7th. Finally, Truist Financial lowered Sabra Health Care REIT from a "buy" rating to a "hold" rating and reduced their price objective for the company from $18.00 to $17.00 in a research note on Friday, January 17th.
Read Our Latest Analysis on Sabra Health Care REIT
Sabra Health Care REIT Trading Up 1.0 %
SBRA stock traded up $0.16 during midday trading on Thursday, hitting $16.61. The stock had a trading volume of 2,969,923 shares, compared to its average volume of 2,086,993. The company's 50-day moving average price is $16.77 and its 200 day moving average price is $17.62. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. Sabra Health Care REIT has a 12-month low of $13.31 and a 12-month high of $20.03. The firm has a market cap of $3.95 billion, a PE ratio of 31.34, a price-to-earnings-growth ratio of 1.97 and a beta of 1.25.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, hitting the consensus estimate of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The business had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. On average, equities research analysts predict that Sabra Health Care REIT will post 1.45 earnings per share for the current fiscal year.
Sabra Health Care REIT Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.22%. The ex-dividend date of this dividend was Friday, February 14th. Sabra Health Care REIT's dividend payout ratio is presently 226.42%.
Institutional Investors Weigh In On Sabra Health Care REIT
A number of large investors have recently modified their holdings of the stock. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Sabra Health Care REIT during the 4th quarter worth approximately $14,241,000. Jefferies Financial Group Inc. purchased a new stake in shares of Sabra Health Care REIT during the fourth quarter valued at approximately $348,000. Mackenzie Financial Corp raised its stake in shares of Sabra Health Care REIT by 22.1% during the fourth quarter. Mackenzie Financial Corp now owns 289,870 shares of the real estate investment trust's stock valued at $5,021,000 after purchasing an additional 52,441 shares during the period. GF Fund Management CO. LTD. acquired a new position in shares of Sabra Health Care REIT during the fourth quarter worth $74,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Sabra Health Care REIT by 2.9% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,444,703 shares of the real estate investment trust's stock valued at $25,022,000 after purchasing an additional 40,127 shares during the period. Institutional investors and hedge funds own 99.40% of the company's stock.
About Sabra Health Care REIT
(
Get Free ReportSabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Read More

Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.